PUBLICATIONS OSLO FLOW CYTOMETRY CORE FACILITY 2021-2024
(1-226)
1. Aarskog, N.R., Aass, H.C., Holter, J.C., Rostrup, M. and Holten, A.R. (2021) Interleukin-6 in Critical Coronavirus Disease 2019, a Driver of Lung Inflammation of Systemic Origin? Crit Care Explor, 3, e0542.
2. Aarsund, M., Segers, F.M., Wu, Y. and Inngjerdingen, M. (2022) Comparison of characteristics and tumor targeting properties of extracellular vesicles derived from primary NK cells or NK-cell lines stimulated with IL-15 or IL-12/15/18. Cancer Immunol Immunother, 71, 2227-2238.
3. Aksnes, M., Aass, H.C.D., Tiiman, A., Edwin, T.H., Terenius, L., Bogdanovic, N., Vukojevic, V. and Knapskog, A.B. (2021) Associations of cerebrospinal fluid amyloidogenic nanoplaques with cytokines in Alzheimer's disease. Transl Neurodegener, 10, 18.
4. Aksnes, M., Aass, H.C.D., Tiiman, A., Terenius, L., Bogdanovic, N., Vukojevic, V. and Knapskog, A.B. (2022) Serum Amyloidogenic Nanoplaques and Cytokines in Alzheimer's Disease: Pilot Study in a Small Naturalistic Memory Clinic Cohort. J Alzheimers Dis, 86, 1459-1470.
5. Al Outa, A., Hicks, S., Thambawita, V., Andresen, S., Enserink, J.M., Halvorsen, P., Riegler, M.A. and Knaevelsrud, H. (2023) CELLULAR, A Cell Autophagy Imaging Dataset. Sci Data, 10, 806.
6. Ali, M., Giannakopoulou, E., Li, Y., Lehander, M., Virding Culleton, S., Yang, W., Knetter, C., Odabasi, M.C., Bollineni, R.C., Yang, X., Foldvari, Z., Boschen, M.L., Taraldsrud, E., Stronen, E., Toebes, M., Hillen, A., Mazzi, S., de Ru, A.H., Janssen, G.M.C., Kolstad, A., Tjonnfjord, G.E., Lie, B.A., Griffioen, M., Lehmann, S., Osnes, L.T., Buechner, J., Garcia, K.C., Schumacher, T.N., van Veelen, P.A., Leisegang, M., Jacobsen, S.E.W., Woll, P. and Olweus, J. (2022) T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes. Nat Biotechnol, 40, 488-498.
7. Amundsen, S.F., Stamnaes, J., du Pre, M.F. and Sollid, L.M. (2022) Transglutaminase 2 affinity and enzyme-substrate intermediate stability as determining factors for T-cell responses to gluten peptides in celiac disease. Eur J Immunol, 52, 1474-1481.
8. Anda, E.E., Braaten, T., Borch, K.B., Nost, T.H., Chen, S.L.F., Lukic, M., Lund, E., Forland, F., Leon, D.A., Winje, B.A., Kran, A.B., Kalager, M., Johansen, F.L. and Sandanger, T.M. (2022) Seroprevalence of antibodies against SARS-CoV-2 in the adult population during the pre-vaccination period, Norway, winter 2020/21. Euro Surveill, 27.
9. Andersen, T.K., Bodin, J., Oftung, F., Bogen, B., Mjaaland, S. and Grodeland, G. (2021) Pandemic Preparedness Against Influenza: DNA Vaccine for Rapid Relief. Front Immunol, 12, 747032.
10. Andresen, N.K., Rossevold, A.H., Quaghebeur, C., Gilje, B., Boge, B., Gombos, A., Falk, R.S., Mathiesen, R.R., Julsrud, L., Garred, O., Russnes, H.G., Lereim, R.R., Chauhan, S.K., Lingjaerde, O.C., Dunn, C., Naume, B. and Kyte, J.A. (2024) Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial. J Immunother Cancer, 12.
11. Asberg, A., Hovd, M., Kjellevold, S.A., Stenehjem, A.E., Wien, T.N., Broch, L.U., Reier-Nielsen, M., Qvale, T.H., Marti, H.P., Heldal, K., Bitter, J., Hagelsteen Kvien, E., Vaage, J.T., Lund-Johansen, F. and Midtvedt, K. (2023) Humoral Response After 6 or More Successive Doses of SARS-CoV-2 mRNA Vaccines in Kidney Transplant Recipients-Should We Keep Vaccinating? Transplantation, 107, e279-e280.
12. Ask, E.H., Tschan-Plessl, A., Hoel, H.J., Kolstad, A., Holte, H. and Malmberg, K.J. (2024) MetaGate: Interactive analysis of high-dimensional cytometry data with metadata integration. Patterns (N Y), 5, 100989.
13. Atlasy, N., Bujko, A., Baekkevold, E.S., Brazda, P., Janssen-Megens, E., Lundin, K.E.A., Jahnsen, J., Jahnsen, F.L. and Stunnenberg, H.G. (2022) Single cell transcriptomic analysis of the immune cell compartment in the human small intestine and in Celiac disease. Nat Commun, 13, 4920.
14. Bai, B., Wise, J.F., Vodak, D., Nakken, S., Sharma, A., Blaker, Y.N., Brodtkorb, M., Hilden, V., Troen, G., Ren, W., Lorenz, S., Lawrence, M.S., Myklebost, O., Kimby, E., Pan-Hammarstrom, Q., Steen, C.B., Meza-Zepeda, L.A., Beiske, K., Smeland, E.B., Hovig, E., Lingjaerde, O.C., Holte, H. and Myklebust, J.H. (2024) Multi-omics profiling of longitudinal samples reveals early genomic changes in follicular lymphoma. Blood Cancer J, 14, 147.
15. Bajor, M., Graczyk-Jarzynka, A., Marhelava, K., Burdzinska, A., Muchowicz, A., Goral, A., Zhylko, A., Soroczynska, K., Retecki, K., Krawczyk, M., Klopotowska, M., Pilch, Z., Paczek, L., Malmberg, K.J., Walchli, S., Winiarska, M. and Zagozdzon, R. (2022) PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells. J Immunother Cancer, 10.
16. Ballet, B., Behaegel, J., Reppe, S., Consejo, A., Aass, H.C., Utheim, T.P., Koppen, C. and Ni Dhubhghaill, S. (2023) Ocular Surface Homeostasis After Scleral Lens Usage. Eye & contact lens, 49, 459-463.
17. Barkovskaya, A., Goodwin, C.M., Seip, K., Hilmarsdottir, B., Pettersen, S., Stalnecker, C., Engebraaten, O., Briem, E., Der, C.J., Moestue, S.A., Gudjonsson, T., Maelandsmo, G.M. and Prasmickaite, L. (2021) Detection of phenotype-specific therapeutic vulnerabilities in breast cells using a CRISPR loss-of-function screen. Mol Oncol, 15, 2026-2045.
18. Barratt-Due, A., Olsen, I.C., Nezvalova-Henriksen, K., Kasine, T., Lund-Johansen, F., Hoel, H., Holten, A.R., Tveita, A., Mathiessen, A., Haugli, M., Eiken, R., Kildal, A.B., Berg, A., Johannessen, A., Heggelund, L., Dahl, T.B., Skara, K.H., Mielnik, P., Le, L.A.K., Thoresen, L., Ernst, G., Hoff, D.A.L., Skudal, H., Kittang, B.R., Olsen, R.B., Tholin, B., Ystrom, C.M., Skei, N.V., Tran, T., Dudman, S., Andersen, J.T., Hannula, R., Dalgard, O., Finbraten, A.K., Tonby, K., Blomberg, B., Aballi, S., Fladeby, C., Steffensen, A., Muller, F., Dyrhol-Riise, A.M., Troseid, M., Aukrust, P. and trial, N.O.-S. (2021) Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial. Ann Intern Med, 174, 1261-1269.
19. Bartok, O., Pataskar, A., Nagel, R., Laos, M., Goldfarb, E., Hayoun, D., Levy, R., Korner, P.R., Kreuger, I.Z.M., Champagne, J., Zaal, E.A., Bleijerveld, O.B., Huang, X., Kenski, J., Wargo, J., Brandis, A., Levin, Y., Mizrahi, O., Alon, M., Lebon, S., Yang, W., Nielsen, M.M., Stern-Ginossar, N., Altelaar, M., Berkers, C.R., Geiger, T., Peeper, D.S., Olweus, J., Samuels, Y. and Agami, R. (2021) Anti-tumour immunity induces aberrant peptide presentation in melanoma. Nature, 590, 332-337.
20. Bartolome-Casado, R., Landsverk, O.J.B., Chauhan, S.K., Saetre, F., Hagen, K.T., Yaqub, S., Oyen, O., Horneland, R., Aandahl, E.M., Aabakken, L., Baekkevold, E.S. and Jahnsen, F.L. (2021) CD4(+) T cells persist for years in the human small intestine and display a T(H)1 cytokine profile. Mucosal Immunol, 14, 402-410.
21. Bay, L.T.E., Stokke, T., Syljuasen, R.G. and Landsverk, H.B. (2023) Analysis of RNA Polymerase II Chromatin Binding by Flow Cytometry. Bio Protoc, 13, e4659.
22. Bay, L.T.E., Syljuasen, R.G. and Landsverk, H.B. (2022) A novel, rapid and sensitive flow cytometry method reveals degradation of promoter proximal paused RNAPII in the presence and absence of UV. Nucleic Acids Res, 50, e89.
23. Beck, C., Casey, N.P., Persiconi, I., Moharrami, N.N., Sike, A., Jin, Y. and Kyte, J.A. (2023) Development of a TGFbeta-IL-2/15 Switch Receptor for Use in Adoptive Cell Therapy. Biomedicines, 11, 459.
24. Bern, M., Anthi, A., Benjakul, S., Kolderup, A., Vaage, E., Lode, H., Vaysburd, M., Nilsen, J., Nyquist-Andersen, M., Sakya, S., Gjølberg, T., Foss, S., Moe, M., Low, B., Wiles, M., Vaage, J., Grodeland, G., Sandlie, I., James, L., Lund-Johansen, F. and Andersen, J.T. (2022). Research Square.
25. Bjerager, J., Magno, M., Chen, X., Belmouhand, M., Aass, H.C.D., Reppe, S., Heegaard, S., Larsen, M. and Utheim, T.P. (2024) Heritability of tear fluid cytokines in healthy twins. Ocul Surf, 32, 145-153.
26. Bjornetro, T., Steffensen, L.A., Vestad, B., Brusletto, B.S., Olstad, O.K., Troseid, A.M., Aass, H.C.D., Haug, K.B.F., Llorente, A., Boe, S.O., Lang, A., Samiappan, R., Redalen, K.R., Ovstebo, R. and Ree, A.H. (2021) Uptake of circulating extracellular vesicles from rectal cancer patients and differential responses by human monocyte cultures. FEBS Open Bio, 11, 724-740.
27. Boix-Lemonche, G., Nagymihaly, R.M., Niemi, E.M., Josifovska, N., Johansen, S., Moe, M.C., Scholz, H. and Petrovski, G. (2023) Intracorneal Implantation of 3D Bioprinted Scaffolds Containing Mesenchymal Stromal Cells Using Femtosecond-Laser-Assisted Intrastromal Keratoplasty. Macromolecular bioscience, 23, e2200422.
28. Bousquet, P.A., Meltzer, S., Fuglestad, A.J., Luders, T., Esbensen, Y., Juul, H.V., Johansen, C., Lyckander, L.G., Bjornetro, T., Inderberg, E.M., Kersten, C., Redalen, K.R. and Ree, A.H. (2022) The mitochondrial DNA constitution shaping T-cell immunity in patients with rectal cancer at high risk of metastatic progression. Clin Transl Oncol, 24, 1157-1167.
29. Braten, L.C.H., Gjefsen, E., Gervin, K., Pripp, A.H., Skouen, J.S., Schistad, E., Pedersen, L.M., Wigemyr, M., Selmer, K.K., Aass, H.C.D., Goll, G., Brox, J.I., Espeland, A., Grovle, L., Zwart, J.A., Storheim, K. and group, A.I.-s. (2023) Cytokine Patterns as Predictors of Antibiotic Treatment Effect in Chronic Low Back Pain with Modic Changes: Subgroup Analyses of a Randomized Trial (AIM Study). Journal of pain research, 16, 1713-1724.
30. Brobak, K.M., Halvorsen, L.V., Aass, H.C.D., Soraas, C.L., Aune, A., Olsen, E., Bergland, O.U., Rognstad, S., Blom, K.B., Birkeland, J.A.K., Hoieggen, A., Larstorp, A.C.K. and Solbu, M.D. (2024) Novel biomarkers in patients with uncontrolled hypertension with and without kidney damage. Blood Press, 33, 2323980.
31. Brunvoll, S.H., Nygaard, A.B., Ellingjord-Dale, M., Holland, P., Istre, M.S., Kalleberg, K.T., Soraas, C.L., Holven, K.B., Ulven, S.M., Hjartaker, A., Haider, T., Lund-Johansen, F., Dahl, J.A., Meyer, H.E. and Soraas, A. (2022) Prevention of covid-19 and other acute respiratory infections with cod liver oil supplementation, a low dose vitamin D supplement: quadruple blinded, randomised placebo controlled trial. BMJ, 378, e071245.
32. Busek, M., Aizenshtadt, A., Koch, T., Frank, A., Delon, L., Martinez, M.A., Golovin, A., Dumas, C., Stokowiec, J., Gruenzner, S., Melum, E. and Krauss, S. (2023) Pump-less, recirculating organ-on-a-chip (rOoC) platform. Lab Chip, 23, 591-608.
33. Caddy, S.L., Vaysburd, M., Papa, G., Wing, M., O'Connell, K., Stoycheva, D., Foss, S., Terje Andersen, J., Oxenius, A. and James, L.C. (2021) Viral nucleoprotein antibodies activate TRIM21 and induce T cell immunity. EMBO J, 40, e106228.
34. Casey, N.P., Klee, C.H., Fane, A., Caulier, B., Graczyk-Jarzynka, A., Krawczyk, M., Fidyt, K., Josefsson, S.E., Koksal, H., Dillard, P., Patkowska, E., Firczuk, M., Smeland, E.B., Winiarska, M., Myklebust, J.H., Inderberg, E.M. and Walchli, S. (2023) Efficient chimeric antigen receptor targeting of a central epitope of CD22. J Biol Chem, 299, 104883.
35. Casey, N.P., Kleinmanns, K., Forcados, C., Gelebart, P.F., Joaquina, S., Lode, M., Benard, E., Kaveh, F., Caulier, B., Helgestad Gjerde, C., Garcia de Jalon, E., Warren, D.J., Lindemann, K.,
Rokkones, E., Davidson, B., Myhre, M.R., Kvalheim, G., Bjorge, L., McCormack, E., Inderberg, E.M. and Walchli, S. (2024) Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16. J Immunother Cancer, 12.
36. Caulier, B., Joaquina, S., Gelebart, P., Dowling, T.H., Kaveh, F., Thomas, M., Tandaric, L., Wernhoff, P., Katyayini, N.U., Wogsland, C., Gjerstad, M.E., Floisand, Y., Kvalheim, G., Marr, C., Kobold, S., Enserink, J.M., Gjertsen, B.T., McCormack, E., Inderberg, E.M. and Walchli, S. (2024) CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemia. Cell Rep Med, 5, 101572.
37. Chaban, V., de Boer, E., McAdam, K.E., Vaage, J., Mollnes, T.E., Nilsson, P.H., Pischke, S.E. and Islam, R. (2023) Escherichia coli-induced inflammatory responses are temperature-dependent in human whole blood ex vivo. Mol Immunol, 157, 70-77.
38. Chauhan, S.K., Bartolome Casado, R., Landsverk, O.J.B., Johannessen, H., Phung, D., Nilsen, H.R., Saetre, F., Jahnsen, J., Horneland, R., Yaqub, S., Aandahl, E.M., Lundin, K.E.A., Baekkevold, E.S. and Jahnsen, F.L. (2023) Human small intestine contains 2 functionally distinct regulatory T-cell subsets. J Allergy Clin Immunol, 152, 278-289 e276.
39. Chauhan, S.K., Dunn, C., Andresen, N.K., Rossevold, A.H., Skorstad, G., Sike, A., Gilje, B., Raj, S.X., Huse, K., Naume, B. and Kyte, J.A. (2024) Peripheral immune cells in metastatic breast cancer patients display a systemic immunosuppressed signature consistent with chronic inflammation. NPJ Breast Cancer, 10, 30.
40. Chellappa, S., Kushekhar, K., Hagness, M., Horneland, R., Tasken, K. and Aandahl, E.M. (2021) The Presence of Activated T Cell Subsets prior to Transplantation Is Associated with Increased Rejection Risk in Pancreas Transplant Recipients. J Immunol, 207, 2501-2511.
41. Chlubnová, M., Christophersen, A.O., Sandve, G.K.F., Lundin, K.E.A., Jahnsen, J., Dahal-Koirala, S. and Sollid, L.M. (2023) Identification of gluten T cell epitopes driving celiac disease. Sci Adv, 9, eade5800.
42. Christensen, I.E., Jyssum, I., Tveter, A.T., Sexton, J., Tran, T.T., Mjaaland, S., Kro, G.B., Kvien, T.K., Warren, D.J., Jahnsen, J., Munthe, L.A., Haavardsholm, E.A., Vaage, J.T., Grodeland, G., Lund-Johansen, F., Jorgensen, K.K., Syversen, S.W., Goll, G.L. and Provan, S.A. (2022) The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls-a prospective cohort study. BMC Med, 20, 378.
43. Christophersen, A., Dahal-Koirala, S., Chlubnova, M., Jahnsen, J., Lundin, K.E.A. and Sollid, L.M. (2022) Phenotype-Based Isolation of Antigen-Specific CD4(+) T Cells in Autoimmunity: A Study of Celiac Disease. Adv Sci (Weinh), 9, e2104766.
44. Christophersen, A., Zuhlke, S., Lund, E.G., Snir, O., Dahal-Koirala, S., Risnes, L.F., Jahnsen, J., Lundin, K.E.A. and Sollid, L.M. (2021) Pathogenic T Cells in Celiac Disease Change Phenotype on Gluten Challenge: Implications for T-Cell-Directed Therapies. Adv Sci (Weinh), 8, e2102778.
45. Clement, D., Szabo, E.K., Krokeide, S.Z., Wiiger, M.T., Vincenti, M., Palacios, D., Chang, Y.T., Grimm, C., Patel, S., Stenmark, H., Brech, A., Majhi, R.K. and Malmberg, K.J. (2023) The Lysosomal Calcium Channel TRPML1 Maintains Mitochondrial Fitness in NK Cells through Interorganelle Cross-Talk. J Immunol, 211, 1348-1358.
46. Cross, T., Haug, K.B.F., Brusletto, B.S., Ommundsen, S.K., Troseid, A.S., Aspelin, T., Olstad, O.K., Aass, H.C.D., Galtung, H.K., Utheim, T.P., Jensen, J.L. and Ovstebo, R. (2023) Non-Coding RNA in Salivary Extracellular Vesicles: A New Frontier in Sjogren's Syndrome Diagnostics? Int J Mol Sci, 24.
47. Dahal-Koirala, S., Risnes, L.F., Neumann, R.S., Christophersen, A., Lundin, K.E.A., Sandve, G.K., Qiao, S.W. and Sollid, L.M. (2021) Comprehensive Analysis of CDR3 Sequences in Gluten-
Specific T-Cell Receptors Reveals a Dominant R-Motif and Several New Minor Motifs. Front Immunol, 12, 639672.
48. Dahl, J., Ormstad, H., Aass, H.C.D., Malt, U.F. and Andreassen, O.A. (2024) Changes in pain during a depressive episode and relationship to cytokine levels in major depressive disorder. Nord J Psychiatry, 78, 181-188.
49. Dalmao-Fernandez, A., Aizenshtadt, A., Bakke, H.G., Krauss, S., Rustan, A.C., Thoresen, G.H. and Kase, E.T. (2023) Development of three-dimensional primary human myospheres as culture model of skeletal muscle cells for metabolic studies. Front Bioeng Biotechnol, 11, 1130693.
50. Das, S., Stamnaes, J., Hoydahl, L.S., Skagen, C., Lundin, K.E.A., Jahnsen, J., Sollid, L.M. and Iversen, R. (2024) Selective activation of naive B cells with unique epitope specificity shapes autoantibody formation in celiac disease. J Autoimmun, 146, 103241.
51. Das, S., Stamnaes, J., Kemppainen, E., Hervonen, K., Lundin, K.E.A., Parmar, N., Jahnsen, F.L., Jahnsen, J., Lindfors, K., Salmi, T., Iversen, R. and Sollid, L.M. (2023) Separate Gut Plasma Cell Populations Produce Auto-Antibodies against Transglutaminase 2 and Transglutaminase 3 in Dermatitis Herpetiformis. Adv Sci (Weinh), 10, e2300401.
52. de Boer, E., Sokolova, M., Quach, H.Q., McAdam, K.E., Götz, M.P., Chaban, V., Vaage, J., Fageräng, B., Woodruff, T.M., Garred, P., Nilsson, P.H., Mollnes, T.E. and Pischke, S.E. (2022) Synthetic Oligodeoxynucleotide CpG Motifs Activate Human Complement through Their Backbone Structure and Induce Complement-Dependent Cytokine Release. J Immunol, 209, 1760-1767.
53. Dewan, A.E., Koentgen, F., Johannesen, M.K., du Pre, M.F. and Sollid, L.M. (2021) Generation of an HLA-DQ2.5 Knock-In Mouse. Immunohorizons, 5, 25-32.
54. Didriksen, H., Molberg, O., Mehta, A., Jordan, S., Palchevskiy, V., Fretheim, H., Gude, E., Ueland, T., Brunborg, C., Garen, T., Midtvedt, O., Andreassen, A.K., Lund-Johansen, F., Distler, O., Belperio, J. and Hoffmann-Vold, A.M. (2022) Target organ expression and biomarker characterization of chemokine CCL21 in systemic sclerosis associated pulmonary arterial hypertension. Front Immunol, 13, 991743.
55. Dillard, P., Casey, N., Pollmann, S., Vernhoff, P., Gaudernack, G., Kvalheim, G., Walchli, S. and Inderberg, E.M. (2021) Targeting KRAS mutations with HLA class II-restricted TCRs for the treatment of solid tumors. Oncoimmunology, 10, 1936757.
56. Dillard, P., Koksal, H., Maggadottir, S.M., Winge-Main, A., Pollmann, S., Menard, M., Myhre, M.R., Maelandsmo, G.M., Florenes, V.A., Gaudernack, G., Kvalheim, G., Walchli, S. and Inderberg, E.M. (2021) Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy. Mol Ther, 29, 1199-1213.
57. Domanska, D., Majid, U., Karlsen, V.T., Merok, M.A., Beitnes, A.R., Yaqub, S., Baekkevold, E.S. and Jahnsen, F.L. (2022) Single-cell transcriptomic analysis of human colonic macrophages reveals niche-specific subsets. J Exp Med, 219.
58. Eek Mariampillai, A., Hauge, S., Kongsrud, K. and Syljuasen, R.G. (2023) Immunogenic cell death after combined treatment with radiation and ATR inhibitors is dually regulated by apoptotic caspases. Front Immunol, 14, 1138920.
59. Fagerang, B., Lau, C., Mc Adam, K.E., Schjalm, C., Christiansen, D., Garred, P., Nilsson, P.H. and Mollnes, T.E. (2024) A novel selective leukocyte depletion human whole blood model reveals the specific roles of monocytes and granulocytes in the cytokine response to Escherichia coli. J Leukoc Biol, 115, 647-663.
60. Fane, A., Myhre, M.R., Inderberg, E.M. and Walchli, S. (2022) In vivo experimental mouse model to test CD19CAR T cells generated with different methods. Methods Cell Biol, 167, 149-161.
61. Federico, L., Malone, B., Tennoe, S., Chaban, V., Osen, J.R., Gainullin, M., Smorodina, E., Kared, H., Akbar, R., Greiff, V., Stratford, R., Clancy, T. and Munthe, L.A. (2023) Experimental validation of immunogenic SARS-CoV-2 T cell epitopes identified by artificial intelligence. Front Immunol, 14, 1265044.
62. Federico, L., Tvedt, T.H.A., Gainullin, M., Osen, J.R., Chaban, V., Lund, K.P., Tietze, L., Tran, T.T., Lund-Johansen, F., Kared, H., Lind, A., Vaage, J.T., Stratford, R., Tennoe, S., Malone, B., Clancy, T., Myhre, A.E.L., Gedde-Dahl, T. and Munthe, L.A. (2023) Robust spike-specific CD4(+) and CD8(+) T cell responses in SARS-CoV-2 vaccinated hematopoietic cell transplantation recipients: a prospective, cohort study. Front Immunol, 14, 1210899.
63. Flatmark, K., Torgunrud, A., Fleten, K.G., Davidson, B., Juul, H.V., Mensali, N., Lund-Andersen, C. and Inderberg, E.M. (2021) Peptide vaccine targeting mutated GNAS: a potential novel treatment for pseudomyxoma peritonei. J Immunother Cancer, 9.
64. Foldvari, Z., Knetter, C., Yang, W., Gjerdingen, T.J., Bollineni, R.C., Tran, T.T., Lund-Johansen, F., Kolstad, A., Drousch, K., Klopfleisch, R., Leisegang, M. and Olweus, J. (2023) A systematic safety pipeline for selection of T-cell receptors to enter clinical use. NPJ Vaccines, 8, 126.
65. Foss, S., Jonsson, A., Bottermann, M., Watkinson, R., Lode, H.E., McAdam, M.B., Michaelsen, T.E., Sandlie, I., James, L.C. and Andersen, J.T. (2022) Potent TRIM21 and complement-dependent intracellular antiviral immunity requires the IgG3 hinge. Sci Immunol, 7, eabj1640.
66. Frafjord, A., Buer, L., Hammarstrom, C., Aamodt, H., Woldbaek, P.R., Brustugun, O.T., Helland, A., Oynebraten, I. and Corthay, A. (2021) The Immune Landscape of Human Primary Lung Tumors Is Th2 Skewed. Front Immunol, 12, 764596.
67. Frick, R., Hoydahl, L.S., Hodnebrug, I., Vik, E.S., Dalhus, B., Sollid, L.M., Gray, J.J., Sandlie, I. and Loset, G.A. (2022) Affinity maturation of TCR-like antibodies using phage display guided by structural modeling. Protein Eng Des Sel, 35.
68. Frick, R., Hoydahl, L.S., Petersen, J., du Pre, M.F., Kumari, S., Berntsen, G., Dewan, A.E., Jeliazkov, J.R., Gunnarsen, K.S., Frigstad, T., Vik, E.S., Llerena, C., Lundin, K.E.A., Yaqub, S., Jahnsen, J., Gray, J.J., Rossjohn, J., Sollid, L.M., Sandlie, I. and Loset, G.A. (2021) A high-affinity human TCR-like antibody detects celiac disease gluten peptide-MHC complexes and inhibits T cell activation. Sci Immunol, 6.
69. Fuentes-Martin, R., Ayuda-Duran, P., Hanes, R., Gallego-Yerga, L., Wolterinck, L., Enserink, J.M., Alvarez, R. and Pelaez, R. (2024) Promising anti-proliferative indolic benzenesulfonamides alter mechanisms with sulfonamide nitrogen substituents. Eur J Med Chem, 275, 116617.
70. Gainullin, M., Federico, L., Rokke Osen, J., Chaban, V., Kared, H., Alirezaylavasani, A., Lund-Johansen, F., Wildendahl, G., Jacobsen, J.A., Sarwar Anjum, H., Stratford, R., Tennoe, S., Malone, B., Clancy, T., Vaage, J.T., Henriksen, K., Wusthoff, L. and Munthe, L.A. (2023) People who use drugs show no increase in pre-existing T-cell cross-reactivity toward SARS-CoV-2 but develop a normal polyfunctional T-cell response after standard mRNA vaccination. Front Immunol, 14, 1235210.
71. Giang, K.A., Boxaspen, T., Diao, Y., Nilvebrant, J., Kosugi-Kanaya, M., Kanaya, M., Krokeide, S.Z., Lehmann, F., Svensson Gelius, S., Malmberg, K.J. and Nygren, P.A. (2023) Affibody-based hBCMA x CD16 dual engagers for NK cell-mediated killing of multiple myeloma cells. N Biotechnol, 77, 139-148.
72. Giannakopoulou, E., Lehander, M., Virding Culleton, S., Yang, W., Li, Y., Karpanen, T., Yoshizato, T., Rustad, E.H., Nielsen, M.M., Bollineni, R.C., Tran, T.T., Delic-Sarac, M., Gjerdingen, T.J., Douvlataniotis, K., Laos, M., Ali, M., Hillen, A., Mazzi, S., Chin, D.W.L., Mehta, A., Holm, J.S., Bentzen, A.K., Bill, M., Griffioen, M., Gedde-Dahl, T., Lehmann, S., Jacobsen, S.E.W., Woll, P.S. and Olweus, J. (2023) A T cell receptor targeting a recurrent driver mutation
in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo. Nat Cancer, 4, 1474-1490.
73. Giliberto, M., Thimiri Govinda Raj, D.B., Cremaschi, A., Skanland, S.S., Gade, A., Tjonnfjord, G.E., Schjesvold, F., Munthe, L.A. and Tasken, K. (2022) Ex vivo drug sensitivity screening in multiple myeloma identifies drug combinations that act synergistically. Mol Oncol, 16, 1241-1258.
74. Gilmour, B.C., Corthay, A. and Oynebraten, I. (2024) High production of IL-12 by human dendritic cells stimulated with combinations of pattern-recognition receptor agonists. NPJ Vaccines, 9, 83.
75. Gjefsen, E., Gervin, K., Braten, L.C.H., Goll, G.L., Aass, H.C.D., Schistad, E.I., Wigemyr, M., Pedersen, L.M., Skouen, J.S., Vigeland, M.D., Selmer, K.K., Storheim, K. and Zwart, J.A. (2023) Longitudinal changes of serum cytokines in patients with chronic low back pain and Modic changes. Osteoarthritis and cartilage, 31, 543-547.
76. Gjefsen, E., Gervin, K., Goll, G., Braten, L.C.H., Wigemyr, M., Aass, H.C.D., Vigeland, M.D., Schistad, E., Pedersen, L.M., Pripp, A.H., Storheim, K., Selmer, K.K. and Zwart, J.A. (2021) Macrophage migration inhibitory factor: a potential biomarker for chronic low back pain in patients with Modic changes. RMD Open, 7.
77. Grad, I., Hanes, R., Ayuda-Duran, P., Kuijjer, M.L., Enserink, J.M., Meza-Zepeda, L.A. and Myklebost, O. (2021) Discovery of novel candidates for anti-liposarcoma therapies by medium-scale high-throughput drug screening. PLoS One, 16, e0248140.
78. Haugsten, H.R., Kristoffersen, A.K., Haug, T.M., Soland, T.M., Ovstebo, R., Aass, H.C.D., Enersen, M. and Galtung, H.K. (2023) Isolation, characterization, and fibroblast uptake of bacterial extracellular vesicles from Porphyromonas gingivalis strains. MicrobiologyOpen, 12, e1388.
79. Hedengran, A., Freiberg, J., May Hansen, P., Boix-Lemonche, G., Utheim, T.P., Dartt, D.A., Petrovski, G., Heegaard, S. and Kolko, M. (2024) Comparing the effect of benzalkonium chloride-preserved, polyquad-preserved, and preservative-free prostaglandin analogue eye drops on cultured human conjunctival goblet cells. Journal of optometry, 17, 100481.
80. Heinzelbecker, J., Fauskanger, M., Jonson, I., Krengel, U., Loset, G.A., Munthe, L. and Tveita, A. (2024) Chimeric antigen receptor T cells targeting the GM3(Neu5Gc) ganglioside. Front Immunol, 15, 1331345.
81. Helsingen, L.M., Loberg, M., Refsum, E., Gjostein, D.K., Wieszczy, P., Olsvik, O., Juul, F.E., Barua, I., Jodal, H.C., Herfindal, M., Mori, Y., Jore, S., Lund-Johansen, F., Fretheim, A., Bretthauer, M., Kalager, M. and group, T.R.s. (2021) Covid-19 transmission in fitness centers in Norway - a randomized trial. BMC Public Health, 21, 2103.
82. Hermansen, J.U., Yin, Y., Rein, I.D. and Skanland, S.S. (2024) Immunophenotyping with (phospho)protein profiling and fluorescent cell barcoding for single-cell signaling analysis and biomarker discovery. NPJ Precis Oncol, 8, 107.
83. Hermansen, J.U., Yin, Y., Urban, A., Myklebust, C.V., Karlsen, L., Melvold, K., Tveita, A.A., Tasken, K., Munthe, L.A., Tjonnfjord, G.E. and Skanland, S.S. (2023) A tumor microenvironment model of chronic lymphocytic leukemia enables drug sensitivity testing to guide precision medicine. Cell Death Discov, 9, 125.
84. Hinke, D.M., Andersen, T.K., Gopalakrishnan, R.P., Skullerud, L.M., Werninghaus, I.C., Grodeland, G., Fossum, E., Braathen, R. and Bogen, B. (2022) Antigen bivalency of antigen-presenting cell-targeted vaccines increases B cell responses. Cell Rep, 39, 110901.
85. Hinke, D.M., Anderson, A.M., Katta, K., Laursen, M.F., Tesfaye, D.Y., Werninghaus, I.C., Angeletti, D., Grodeland, G., Bogen, B. and Braathen, R. (2024) Applying valency-based
immuno-selection to generate broadly cross-reactive antibodies against influenza hemagglutinins. Nat Commun, 15, 850.
86. Holm, S., Kared, H., Michelsen, A.E., Kong, X.Y., Dahl, T.B., Schultz, N.H., Nyman, T.A., Fladeby, C., Seljeflot, I., Ueland, T., Stensland, M., Mjaaland, S., Goll, G.L., Nissen-Meyer, L.S., Aukrust, P., Skagen, K., Gregersen, I., Skjelland, M., Holme, P.A., Munthe, L.A. and Halvorsen, B. (2021) Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia. Eur Heart J, 42, 4064-4072.
87. Holmberg, M., Aass, H.C.D., Dalgard, O., Samuelsen, E., Sun, D., Bjorkstrom, N.K., Johannessen, A. and Reikvam, D.H. (2023) Treatment cessation in HBeAg-negative chronic hepatitis B: clinical response is associated with increase in specific proinflammatory cytokines. Sci Rep, 13, 22590.
88. Hovd, M., Asberg, A., Munthe, L.A., Heldal, K., Reisaeter, A.V., Vaage, J.T., Lund-Johansen, F. and Midtvedt, K. (2023) Humoral vaccine response and breakthrough infections in kidney transplant recipients during the COVID-19 pandemic: a nationwide cohort study. EClinicalMedicine, 60, 102035.
89. Humbert, M., Olofsson, A., Wullimann, D., Niessl, J., Hodcroft, E.B., Cai, C., Gao, Y., Sohlberg, E., Dyrdak, R., Mikaeloff, F., Neogi, U., Albert, J., Malmberg, K.J., Lund-Johansen, F., Aleman, S., Bjorkhem-Bergman, L., Jenmalm, M.C., Ljunggren, H.G., Buggert, M. and Karlsson, A.C. (2023) Functional SARS-CoV-2 cross-reactive CD4(+) T cells established in early childhood decline with age. Proc Natl Acad Sci U S A, 120, e2220320120.
90. Huse, K., Bai, B., Hilden, V.I., Bollum, L.K., Vatsveen, T.K., Munthe, L.A., Smeland, E.B., Irish, J.M., Walchli, S. and Myklebust, J.H. (2022) Mechanism of CD79A and CD79B Support for IgM+ B Cell Fitness through B Cell Receptor Surface Expression. J Immunol, 209, 2042-2053.
91. Huynh, T.T.M., Aass, H.C.D., Falk, R.S., Astrup, G.L., Helland, A., Bjoro, T., Bjordal, K., Dale, E., Hellebust, T.P., Herlofson, B.B., Malinen, E., Kiserud, C.E., Osnes, T. and Amdal, C.D. (2023) Associations between patient-reported late effects and systemic cytokines in long-term survivors of head and neck cancer treated with radiotherapy. J Cancer Surviv, 17, 1082-1093.
92. Ibsen, J.H., Chopra, A., Vaage, E.B., Vaage, J.T., Lund-Johansen, F. and Lundin, K.E.A. (2023) Immune responses to SARS-CoV-2 vaccines in celiac disease. Scand J Gastroenterol, 58, 142-147.
93. Imbery, J.F., Heinzelbecker, J., Jebsen, J.K., McGowan, M., Myklebust, C., Bottini, N., Stanford, S.M., Skanland, S.S., Tveita, A., Tjonnfjord, G.E., Munthe, L.A., Szodoray, P. and Nakken, B. (2022) T-helper cell regulation of CD45 phosphatase activity by galectin-1 and CD43 governs chronic lymphocytic leukaemia proliferation. Br J Haematol, 198, 556-573.
94. Imbery, J.F., Wiik, C., Heinzelbecker, J., Jebsen, J.K., Dobbing, M.K., Bottini, N., Stanford, S.M., Munthe, L.A., Tjonnfjord, G.E., Tveita, A., Szodoray, P. and Nakken, B. (2024) CD38 regulates chronic lymphocytic leukemia proliferation via CD45 phosphatase activity. Molecular Therapy Oncology, 32.
95. Jiang, X., Otterdal, K., Chung, B.K., Maucourant, C., Ronneberg, J.D., Zimmer, C.L., Ogaard, J., Boichuk, Y., Holm, S., Geanon, D., Schneditz, G., Bergquist, A., Bjorkstrom, N.K. and Melum, E. (2024) Cholangiocytes Modulate CD100 Expression in the Liver and Facilitate Pathogenic T-Helper 17 Cell Differentiation. Gastroenterology, 166, 667-679.
96. Jin, K.X., Zuo, R., Anastassiadis, K., Klungland, A., Marr, C. and Filipczyk, A. (2021) N6-methyladenosine (m(6)A) depletion regulates pluripotency exit by activating signaling pathways in embryonic stem cells. Proc Natl Acad Sci U S A, 118.
97. Jin, Y., Lorvik, K.B., Jin, Y., Beck, C., Sike, A., Persiconi, I., Kvaloy, E., Saatcioglu, F., Dunn, C. and Kyte, J.A. (2022) Development of STEAP1 targeting chimeric antigen receptor for adoptive cell therapy against cancer. Mol Ther Oncolytics, 26, 189-206.
98. Joaquina, S., Forcados, C., Caulier, B., Inderberg, E.M. and Walchli, S. (2023) Determination of CAR T cell metabolism in an optimized protocol. Front Bioeng Biotechnol, 11, 1207576.
99. Johannessen, J.A., Formica, M., Haukeland, A.L.C., Brathen, N.R., Al Outa, A., Aarsund, M., Therrien, M., Enserink, J.M. and Knaevelsrud, H. (2023) The human leukemic oncogene MLL-AF4 promotes hyperplastic growth of hematopoietic tissues in Drosophila larvae. iScience, 26, 107726.
100. Johnson, C., Quach, H.Q., Lau, C., Ekholt, K., Espevik, T., Woodruff, T.M., Pischke, S.E., Mollnes, T.E. and Nilsson, P.H. (2022) Thrombin Differentially Modulates the Acute Inflammatory Response to Escherichia coli and Staphylococcus aureus in Human Whole Blood. J Immunol, 208, 2771-2778.
101. Johnson, S.U., Hoffart, A., Tilden, T., Toft, H., Neupane, S.P., Lien, L. and Bramness, J.G. (2021) Circulating cytokine levels in the treatment of comorbid anxiety disorders. Acta Neuropsychiatr, 33, 65-71.
102. Jontvedt Jorgensen, M., Nore, K.G., Aass, H.C.D., Layre, E., Nigou, J., Mortensen, R., Tasken, K., Kvale, D., Jenum, S., Tonby, K. and Dyrhol-Riise, A.M. (2021) Plasma LOX-Products and Monocyte Signaling Is Reduced by Adjunctive Cyclooxygenase-2 Inhibitor in a Phase I Clinical Trial of Tuberculosis Patients. Front Cell Infect Microbiol, 11, 669623.
103. Jyssum, I., Kared, H., Tran, T.T., Tveter, A.T., Provan, S.A., Sexton, J., Jorgensen, K.K., Jahnsen, J., Kro, G.B., Warren, D.J., Vaage, E.B., Kvien, T.K., Nissen-Meyer, L.H., Anderson, A.M., Grodeland, G., Haavardsholm, E.A., Vaage, J.T., Mjaaland, S., Syversen, S.W., Lund-Johansen, F., Munthe, L.A. and Goll, G.L. (2022) Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study. Lancet Rheumatol, 4, e177-e187.
104. Kared, H., Alirezaylavasani, A., Lund, K.P., Chopra, A., Tietze, L., de Matos Kasahara, T., Goll, G.L., Grodeland, G., Kaarbo, M., Reisaeter, A.V., Hovd, M., Heldal, K., Vaage, J.T., Lund-Johansen, F., Midtvedt, K., Asberg, A. and Munthe, L.A. (2023) Hybrid and SARS-CoV-2-vaccine immunity in kidney transplant recipients. EBioMedicine, 97, 104833.
105. Kared, H., Jyssum, I., Alirezaylavasani, A., Egner, I.M., The Tran, T., Tietze, L., Lund, K.P., Tveter, A.T., Provan, S.A., Orbo, H., Haavardsholm, E.A., Vaage, J.T., Jorgensen, K., Syversen, S.W., Lund-Johansen, F., Goll, G.L. and Munthe, L.A. (2024) Dynamics of SARS-CoV-2 immunity after vaccination and breakthrough infection in rituximab-treated rheumatoid arthritis patients: a prospective cohort study. Front Immunol, 15, 1296273.
106. Kared, H., Wolf, A.S., Alirezaylavasani, A., Ravussin, A., Solum, G., Tran, T.T., Lund-Johansen, F., Vaage, J.T., Nissen-Meyer, L.S., Nygaard, U.C., Hungnes, O., Robertson, A.H., Naess, L.M., Trogstad, L., Magnus, P., Munthe, L.A. and Mjaaland, S. (2022) Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults. Nat Commun, 13, 4165.
107. Karlsen, T.A., Sundaram, A.Y.M. and Brinchmann, J.E. (2021) Single-Cell RNA Sequencing of In Vitro Expanded Chondrocytes: MSC-Like Cells With No Evidence of Distinct Subsets. Cartilage, 13, 774S-784S.
108. Kasine, T., Dyrhol-Riise, A.M., Barratt-Due, A., Kildal, A.B., Olsen, I.C., Nezvalova-Henriksen, K., Lund-Johansen, F., Hoel, H., Holten, A.R., Tveita, A., Mathiessen, A., Haugli, M., Eiken, R., Berg, A., Johannessen, A., Heggelund, L., Dahl, T.B., Halvorsen, B., Mielnik, P., Le, L.A.K., Thoresen, L., Ernst, G., Hoff, D.A.L., Skudal, H., Kittang, B.R., Olsen, R.B., Tholin, B., Ystrom, C.M., Skei, N.V., Hannula, R., Dalgard, O., Finbraten, A.K., Tonby, K., Aballi, S., Muller, F., Mohn, K.G., Troseid, M., Aukrust, P., Ueland, T. and Group, N.O.-S.S. (2022) Neutrophil count predicts clinical outcome in hospitalized COVID-19 patients: Results from the NOR-Solidarity trial. J Intern Med, 291, 241-243.
109. Khan, A.Z., Utheim, T.P., Moe, M.C., Aass, H.C.D., Sapkota, D., Vallenari, E.M. and Eidet, J.R. (2021) The Silk Protein Sericin Promotes Viability of ARPE-19 and Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelial Cells in vitro. Curr Eye Res, 46, 504-514.
110. Khodeer, S., Klungland, A. and Dahl, J.A. (2022) ALKBH5 regulates somatic cell reprogramming in a phase-specific manner. J Cell Sci, 135.
111. Koirala, R., Aass, H.C.D., Soegaard, E.G.I., Dhakal, H.P., Ojha, S.P., Hauff, E. and Thapa, S.B. (2023) Association of pro-inflammatory cytokines with trauma and post-traumatic stress disorder visiting a tertiary care hospital in Kathmandu. PLoS One, 18, e0281125.
112. Koksal, H., Dillard, P., Juzeniene, A., Kvalheim, G., Smeland, E.B., Myklebust, J.H., Inderberg, E.M. and Walchli, S. (2021) Combinatorial CAR design improves target restriction. J Biol Chem, 296, 100116.
113. Konig, M., Lorentzen, A.R., Torgauten, H.M., Tran, T.T., Schikora-Rustad, S., Vaage, E.B., Mygland, A., Wergeland, S., Aarseth, J., Aaberge, I.A.S., Torkildsen, O., Holmoy, T., Berge, T., Myhr, K.M., Harbo, H.F., Andersen, J.T., Munthe, L.A., Soraas, A., Celius, E.G., Vaage, J.T., Lund-Johansen, F. and Nygaard, G.O. (2023) Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations. J Neurol Neurosurg Psychiatry, 94, 19-22.
114. Konig, M., Torgauten, H.M., Tran, T.T., Holmoy, T., Vaage, J.T., Lund-Johansen, F. and Nygaard, G.O. (2022) Immunogenicity and Safety of a Third SARS-CoV-2 Vaccine Dose in Patients With Multiple Sclerosis and Weak Immune Response After COVID-19 Vaccination. JAMA Neurol, 79, 307-309.
115. Lachota, M., Zielniok, K., Palacios, D., Kanaya, M., Penna, L., Hoel, H.J., Wiiger, M.T., Kveberg, L., Hautz, W., Zagozdzon, R. and Malmberg, K.J. (2023) Mapping the chemotactic landscape in NK cells reveals subset-specific synergistic migratory responses to dual chemokine receptor ligation. EBioMedicine, 96, 104811.
116. Lamsal, A., Andersen, S.B., Johansson, I., Vietri, M., Bokil, A.A., Kurganovs, N.J., Rylander, F., Bjorkoy, G., Pettersen, K. and Giambelluca, M.S. (2023) Opposite and dynamic regulation of the interferon response in metastatic and non-metastatic breast cancer. Cell Commun Signal, 21, 50.
117. Landsend, E.C.S., Olafsson, J., Lai, X., Aass, H.C.D. and Utheim, T.P. (2022) Change in Ocular Surface Staining during Eyelid Warming Is Related to Tear Cytokine Levels. J Ophthalmol, 2022, 5103231.
118. Lee, Y., Riskedal, E., Kalleberg, K.T., Istre, M., Lind, A., Lund-Johansen, F., Reiakvam, O., Soraas, A.V.L., Harris, J.R., Dahl, J.A., Hadley, C.L. and Jugessur, A. (2022) EWAS of post-COVID-19 patients shows methylation differences in the immune-response associated gene, IFI44L, three months after COVID-19 infection. Sci Rep, 12, 11478.
119. Lerum, T.V., Maltzahn, N.N., Aukrust, P., Troseid, M., Henriksen, K.N., Kasine, T., Dyrhol-Riise, A.M., Stiksrud, B., Haugli, M., Blomberg, B., Kittang, B.R., Johannessen, A., Hannula, R., Aballi, S., Kildal, A.B., Eiken, R., Dahl, T.B., Lund-Johansen, F., Muller, F., Rodriguez, J.R., Meltzer, C., Einvik, G., Ueland, T., Olsen, I.C., Consortium, N.-S., Barratt-Due, A., Aalokken, T.M. and Skjonsberg, O.H. (2021) Persistent pulmonary pathology after COVID-19 is associated with high viral load, weak antibody response, and high levels of matrix metalloproteinase-9. Sci Rep, 11, 23205.
120. Li, J., Zaslavsky, M., Su, Y., Guo, J., Sikora, M.J., van Unen, V., Christophersen, A., Chiou, S.H., Chen, L., Li, J., Ji, X., Wilhelmy, J., McSween, A.M., Palanski, B.A., Mallajosyula, V.V.A., Bracey, N.A., Dhondalay, G.K.R., Bhamidipati, K., Pai, J., Kipp, L.B., Dunn, J.E., Hauser, S.L., Oksenberg, J.R., Satpathy, A.T., Robinson, W.H., Dekker, C.L., Steinmetz, L.M., Khosla, C., Utz, P.J., Sollid, L.M., Chien, Y.H., Heath, J.R., Fernandez-Becker, N.Q., Nadeau, K.C., Saligrama, N. and Davis,
M.M. (2022) KIR(+)CD8(+) T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19. Science, 376, eabi9591.
121. Lier, S., Lund, S.O., Lipsa, A., Frauenknecht, K.B.M., Rein, I.D., Jain, P., Lång, A.U., Lång, E.H., Meyer, N., Dutta, A., Anand, S., Nesse, G.J., Johansen, R.F., Klungland, A., Rinholm, J.E., Bøe, S.O., Anand, A., Pollard, S.M., Niclou, S.P., Lerdrup, M. and Pandey, D.P. (2023) CDK12/CDK13 inhibition disrupts a transcriptional program critical for glioblastoma survival. bioRxiv, 2023.2007.2014.548985.
122. Lindeman, I., Høydahl, L.S., Christophersen, A., Risnes, L.F., Jahnsen, J., Lundin, K.E.A., Sollid, L.M. and Iversen, R. (2024) Generation of circulating autoreactive pre-plasma cells fueled by naive B cells in celiac disease. Cell Rep, 43, 114045.
123. Lindeman, I., Polak, J., Qiao, S.W., Holmoy, T., Hoglund, R.A., Vartdal, F., Berg-Hansen, P., Sollid, L.M. and Lossius, A. (2022) Stereotyped B-cell responses are linked to IgG constant region polymorphisms in multiple sclerosis. Eur J Immunol, 52, 550-565.
124. Lindeman, I., Zhou, C., Eggesbo, L.M., Miao, Z., Polak, J., Lundin, K.E.A., Jahnsen, J., Qiao, S.W., Iversen, R. and Sollid, L.M. (2021) Longevity, clonal relationship, and transcriptional program of celiac disease-specific plasma cells. J Exp Med, 218.
125. Lindstad, C.B., Dewan, A.E., Stamnaes, J., Sollid, L.M. and du Pre, M.F. (2021) TG2-gluten complexes as antigens for gluten-specific and transglutaminase-2 specific B cells in celiac disease. PLoS One, 16, e0259082.
126. Lindstad, C.B., du Pre, M.F., Stamnaes, J. and Sollid, L.M. (2022) Injection of prototypic celiac anti-transglutaminase 2 antibodies in mice does not cause enteropathy. PLoS One, 17, e0266543.
127. Lindstad, C.B., Qiao, S.W., Johannesen, M.K., Fugger, L., Sollid, L.M. and du Pre, M.F. (2021) Characterization of T-cell receptor transgenic mice recognizing immunodominant HLA-DQ2.5-restricted gluten epitopes. Eur J Immunol, 51, 1002-1005.
128. Lorvik, K.B., Meyer-Myklestad, M.H., Kushekar, K., Handeland, C., Medhus, A.W., Lund-Iversen, M., Stiksrud, B., Kvale, D., Dyrhol-Riise, A.M., Tasken, K. and Reikvam, D.H. (2021) Enhanced Gut-Homing Dynamics and Pronounced Exhaustion of Mucosal and Blood CD4(+) T Cells in HIV-Infected Immunological Non-Responders. Front Immunol, 12, 744155.
129. Lysen, A., Gudjonsson, A., Tesfaye, D.Y., Bobic, S., Bern, M., Bogen, B. and Fossum, E. (2022) Intranasal delivery of a cDC1 targeted influenza vaccine with poly(I:C) enhances T cell responses and protects against influenza infection. Scand J Immunol, 95, e13128.
130. Maggadottir, S.M., Dueland, S., Mensali, N., Hamre, H., Andresen, P.A., Myhre, M.R., Juul, H.V., Bigalke, I., Lundby, M., Honnashagen, T.K., Saeboe-Larssen, S., Josefsen, D., Hagtvedt, T., Walchli, S., Kvalheim, G. and Inderberg, E.M. (2024) Transient TCR-based T cell therapy in a patient with advanced treatment-resistant MSI-high colorectal cancer. Mol Ther, 32, 2021-2029.
131. Malecka, A., Ostlie, I., Troen, G., Malecki, J., Delabie, J., Tierens, A., Munthe, L.A., Berentsen, S. and Tjonnfjord, G.E. (2024) Gene expression analysis revealed downregulation of complement receptor 1 in clonal B cells in cold agglutinin disease. Clin Exp Immunol, 216, 45-54.
132. Malmin, A., Thomseth, V.M., Forland, P.T., Aass, H.C.D., Reppe, S., Olsen, M.V.T., Lindtjorn, B., Chen, X., Haugen, I.B.K., Utheim, T.P. and Forsaa, V.A. (2024) Tear cytokine levels are reduced in patients treated with intravitreal injections. Ocul Surf, 32, 222-226.
133. Mandrup, O.A., Ong, S.C., Lykkemark, S., Dinesen, A., Rudnik-Jansen, I., Dagnaes-Hansen, N.F., Andersen, J.T., Alvarez-Vallina, L. and Howard, K.A. (2021) Programmable half-life and anti-tumour effects of bispecific T-cell engager-albumin fusions with tuned FcRn affinity. Commun Biol, 4, 310.
134. Marsh, P.L., Moore, E.E., Moore, H.B., Bunch, C.M., Aboukhaled, M., Condon, S.M., 2nd, Al-Fadhl, M.D., Thomas, S.J., Larson, J.R., Bower, C.W., Miller, C.B., Pearson, M.L., Twilling, C.L.,
Reser, D.W., Kim, G.S., Troyer, B.M., Yeager, D., Thomas, S.G., Srikureja, D.P., Patel, S.S., Anon, S.L., Thomas, A.V., Miller, J.B., Van Ryn, D.E., Pamulapati, S.V., Zimmerman, D., Wells, B., Martin, P.L., Seder, C.W., Aversa, J.G., Greene, R.B., March, R.J., Kwaan, H.C., Fulkerson, D.H., Vande Lune, S.A., Mollnes, T.E., Nielsen, E.W., Storm, B.S. and Walsh, M.M. (2023) Iatrogenic air embolism: pathoanatomy, thromboinflammation, endotheliopathy, and therapies. Front Immunol, 14, 1230049.
135. Mastrangelopoulou, M., Grigalavicius, M., Raabe, T.H., Skarpen, E., Juzenas, P., Peng, Q., Berg, K. and Theodossiou, T.A. (2022) Predictive biomarkers for 5-ALA-PDT can lead to personalized treatments and overcome tumor-specific resistances. Cancer Rep (Hoboken), 5, e1278.
136. Medeiros, P.M.C., Schjalm, C., Christiansen, D., Sokolova, M., Pischke, S.E., Wurzner, R., Mollnes, T.E. and Barratt-Due, A. (2022) Vitamin C, Hydrocortisone, and the Combination Thereof Significantly Inhibited Two of Nine Inflammatory Markers Induced by Escherichia Coli But Not by Staphylococcus Aureus - When Incubated in Human Whole Blood. Shock, 57, 72-80.
137. Meling, M.T., Kleppa, L., Besser, H.A., Khosla, C., du Pre, M.F. and Sollid, L.M. (2024) Enterocyte-Derived and Catalytically Active Transglutaminase 2 in the Gut Lumen of Mice: Implications for Celiac Disease. Gastroenterology.
138. Melvold, K., Giliberto, M., Karlsen, L., Ayuda-Duran, P., Hanes, R., Holien, T., Enserink, J., Brown, J.R., Tjonnfjord, G.E., Tasken, K. and Skanland, S.S. (2022) Mcl-1 and Bcl-xL levels predict responsiveness to dual MEK/Bcl-2 inhibition in B-cell malignancies. Mol Oncol, 16, 1153-1170.
139. Mensali, N., Dillard, P., Fayzullin, A., Koksal, H., Gaudernack, G., Kvalheim, G., Inderberg, E.M. and Walchli, S. (2021) "Built-in" PD-1 blocker to rescue NK-92 activity from PD-L1-mediated tumor escape mechanisms. FASEB J, 35, e21750.
140. Mensali, N., Koksal, H., Joaquina, S., Wernhoff, P., Casey, N.P., Romecin, P., Panisello, C., Rodriguez, R., Vimeux, L., Juzeniene, A., Myhre, M.R., Fane, A., Ramirez, C.C., Maggadottir, S.M., Duru, A.D., Georgoudaki, A.M., Grad, I., Maturana, A.D., Gaudernack, G., Kvalheim, G., Carcaboso, A.M., de Alava, E., Donnadieu, E., Bruland, O.S., Menendez, P., Inderberg, E.M. and Walchli, S. (2023) ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma. Nat Commun, 14, 3375.
141. Meyer, S., Blaas, I., Bollineni, R.C., Delic-Sarac, M., Tran, T.T., Knetter, C., Dai, K.Z., Madssen, T.S., Vaage, J.T., Gustavsen, A., Yang, W., Nissen-Meyer, L.S.H., Douvlataniotis, K., Laos, M., Nielsen, M.M., Thiede, B., Soraas, A., Lund-Johansen, F., Rustad, E.H. and Olweus, J. (2023) Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants. Cell Rep, 42, 111995.
142. Meyer, S., Blaas, I., Bollineni, R.C., Delic-Sarac, M., Tran, T.T., Knetter, C., Dai, K.-Z., Støve Madssen, T., Vaage, J.T., Gustavsen, A., Yang, W., Nissen-Meyer, L.S.H., Douvlataniotis, K., Laos, M., Nielsen, M.M., Thiede, B., Søraas, A., Lund-Johansen, F., Rustad, E.H. and Olweus, J. (2021) Public T-cell epitopes shared among SARS-CoV-2 variants are presented on prevalent HLA class I alleles. bioRxiv, 2021.2010.2013.463911.
143. Meyer-Myklestad, M.H., Medhus, A.W., Lorvik, K.B., Seljeflot, I., Hansen, S.H., Holm, K., Stiksrud, B., Troseid, M., Hov, J.R., Kvale, D., Dyrhol-Riise, A.M., Kummen, M. and Reikvam, D.H. (2022) Human Immunodeficiency Virus-Infected Immunological Nonresponders Have Colon-Restricted Gut Mucosal Immune Dysfunction. J Infect Dis, 225, 661-674.
144. Midtvedt, K., Tran, T., Parker, K., Marti, H.P., Stenehjem, A.E., Goransson, L.G., Morkve Soldal, K., Madsen, C., Smedbraten, J., Vaage, E.B., Lund-Johansen, F. and Asberg, A. (2021) Low Immunization Rate in Kidney Transplant Recipients Also After Dose 2 of the BNT162b2 Vaccine: Continue to Keep Your Guard up! Transplantation, 105, e80-e81.
145. Midtvedt, K., Vaage, J.T., Heldal, K., Munthe, L.A., Lund-Johansen, F. and Asberg, A. (2022) Fourth dose of the SARS-CoV-2 vaccine in kidney transplant recipients with previously impaired humoral antibody response. Am J Transplant, 22, 2704-2706.
146. Migliano, S.M., Schultz, S.W., Wenzel, E.M., Takats, S., Liu, D., Mork, S., Tan, K.W., Rusten, T.E., Raiborg, C. and Stenmark, H. (2024) Removal of hypersignaling endosomes by simaphagy. Autophagy, 20, 769-791.
147. Mohle, L., Stefan, K., Bascunana, P., Brackhan, M., Bruning, T., Eiriz, I., El Menuawy, A., van Genderen, S., Santos-Garcia, I., Gorska, A.M., Villa, M., Wu, J., Stefan, S.M. and Pahnke, J. (2023) ABC Transporter C1 Prevents Dimethyl Fumarate from Targeting Alzheimer's Disease. Biology (Basel), 12.
148. Nahse, V., Raiborg, C., Tan, K.W., Mork, S., Torgersen, M.L., Wenzel, E.M., Nager, M., Salo, V.T., Johansen, T., Ikonen, E., Schink, K.O. and Stenmark, H. (2023) ATPase activity of DFCP1 controls selective autophagy. Nat Commun, 14, 4051.
149. Nilsen, A., Hillestad, T., Skingen, V.E., Aarnes, E.K., Fjeldbo, C.S., Hompland, T., Evensen, T.S., Stokke, T., Kristensen, G.B., Grallert, B. and Lyng, H. (2022) miR-200a/b/-429 downregulation is a candidate biomarker of tumor radioresistance and independent of hypoxia in locally advanced cervical cancer. Mol Oncol, 16, 1402-1419.
150. Nyakas, M., Fleten, K.G., Haugen, M.H., Engedal, N., Sveen, C., Farstad, I.N., Florenes, V.A., Prasmickaite, L., Maelandsmo, G.M. and Seip, K. (2022) AXL inhibition improves BRAF-targeted treatment in melanoma. Sci Rep, 12, 5076.
151. Oksvold, M.P., Berglund, U.W., Gad, H., Bai, B., Stokke, T., Rein, I.D., Pham, T., Sanjiv, K., Oy, G.F., Norum, J.H., Smeland, E.B., Myklebust, J.H., Helleday, T. and Vatsveen, T.K. (2021) Karonudib has potent anti-tumor effects in preclinical models of B-cell lymphoma. Sci Rep, 11, 6317.
152. Okura, Y., Ikawa-Teranishi, Y., Mizoroki, A., Takahashi, N., Tsushima, T., Irie, M., Harfuddin, Z., Miura-Okuda, M., Ito, S., Nakamura, G., Takesue, H., Ozono, Y., Nishihara, M., Yamada, K., Gan, S.W., Hayasaka, A., Ishii, S., Wakabayashi, T., Muraoka, M., Nagaya, N., Hino, H., Nemoto, T., Kuramochi, T., Torizawa, T., Shimada, H., Kitazawa, T., Okazaki, M., Nezu, J., Sollid, L.M. and Igawa, T. (2023) Characterizations of a neutralizing antibody broadly reactive to multiple gluten peptide:HLA-DQ2.5 complexes in the context of celiac disease. Nat Commun, 14, 8502.
153. Oldereid, T.S., Jiang, X., Nordhus, K.S., Ponzetta, A., Bjornholt, J.V., Bjorkstrom, N.K., Melum, E. and Rasmussen, H. (2024) Role of bacteria and microbial metabolites in immune modulation during early life. Scand J Immunol, 99, e13336.
154. Oldereid, T.S., Jiang, X., Ogaard, J., Schrumpf, E., Bjornholt, J.V., Rasmussen, H. and Melum, E. (2024) Microbial exposure during early life regulates development of bile duct inflammation. Scand J Gastroenterol, 59, 192-201.
155. Palacios, D., Momayyezi, P., Huhn, O., Ask, E.H., Dunst, J., Malmberg, K.J. and Hammer, Q. (2022) An optimized platform for efficient siRNA delivery into human NK cells. Eur J Immunol, 52, 1190-1193.
156. Pataskar, A., Champagne, J., Nagel, R., Kenski, J., Laos, M., Michaux, J., Pak, H.S., Bleijerveld, O.B., Mordente, K., Navarro, J.M., Blommaert, N., Nielsen, M.M., Lovecchio, D., Stone, E., Georgiou, G., de Gooijer, M.C., van Tellingen, O., Altelaar, M., Joosten, R.P., Perrakis, A., Olweus, J., Bassani-Sternberg, M., Peeper, D.S. and Agami, R. (2022) Tryptophan depletion results in tryptophan-to-phenylalanine substitutants. Nature, 603, 721-727.
157. Philippon, C., Tao, S., Clement, D., Haroun-Izquierdo, A., Kichula, K.M., Netskar, H., Brandt, L., Oei, V.S., Kanaya, M., Lanuza, P.M., Schaffer, M., Goodridge, J.P., Horowitz, A., Zhu, F., Hammer, Q., Sohlberg, E., Majhi, R.K., Kveberg, L., Onfelt, B., Norman, P.J. and Malmberg, K.J.
(2023) Allelic variation of KIR and HLA tunes the cytolytic payload and determines functional hierarchy of NK cell repertoires. Blood Adv, 7, 4492-4504.
158. Podgorica, M., Drivet, E., Viken, J.K., Richman, A., Vestbostad, J., Szodoray, P., Kvam, A.K., Wik, H.S., Tjonnfjord, G.E., Munthe, L.A., Frietze, S. and Schjerven, H. (2024) Transcriptome analysis of primary adult B-cell lineage acute lymphoblastic leukemia identifies pathogenic variants and gene fusions, and predicts subtypes for in depth molecular diagnosis. Eur J Haematol, 112, 731-742.
159. Polak, J., Wagnerberger, J.H., Torsetnes, S.B., Lindeman, I., Hoglund, R.A.A., Vartdal, F., Sollid, L.M. and Lossius, A. (2023) Single-cell transcriptomics combined with proteomics of intrathecal IgG reveal transcriptional heterogeneity of oligoclonal IgG-secreting cells in multiple sclerosis. Front Cell Neurosci, 17, 1189709.
160. Pust, S., Brech, A., Wegner, C.S., Stenmark, H. and Haglund, K. (2023) Vesicle-mediated transport of ALIX and ESCRT-III to the intercellular bridge during cytokinesis. Cell Mol Life Sci, 80, 235.
161. Qiao, S.W., Dahal-Koirala, S., Eggesbo, L.M., Lundin, K.E.A. and Sollid, L.M. (2021) Frequency of Gluten-Reactive T Cells in Active Celiac Lesions Estimated by Direct Cell Cloning. Front Immunol, 12, 646163.
162. Quach, H.Q., Johnson, C., Ekholt, K., Islam, R., Mollnes, T.E. and Nilsson, P.H. (2022) Platelet-Depletion of Whole Blood Reveals That Platelets Potentiate the Release of IL-8 From Leukocytes Into Plasma in a Thrombin-Dependent Manner. Front Immunol, 13, 865386.
163. Ravussin, A., Robertson, A.H., Wolf, A.S., Blix, K., Kjonstad, I.F., Solum, G., Feiring, B., Strand, B.H., Lund-Johansen, F., Munthe, L.A., Magnus, P., Trogstad, L. and Mjaaland, S. (2023) Determinants of humoral and cellular immune responses to three doses of mRNA SARS-CoV-2 vaccines in older adults: a longitudinal cohort study. Lancet Healthy Longev, 4, e188-e199.
164. Richartz, N., Pietka, W., Yadav, A., Bostad, M., Bhagwat, S., Naderi, S., Naderi, E.H., Stokke, T., Ruud, E. and Blomhoff, H.K. (2024) N-acetyl cysteine turns EPAC activators into potent killers of acute lymphoblastic leukemia cells. J Biol Chem, 300, 105509.
165. Riise, J., Meyer, S., Blaas, I., Chopra, A., Tran, T.T., Delic-Sarac, M., Hestdalen, M.L., Brodin, E., Rustad, E.H., Dai, K.Z., Vaage, J.T., Nissen-Meyer, L.S.H., Sund, F., Wader, K.F., Bjornevik, A.T., Meyer, P.A., Nygaard, G.O., Konig, M., Smeland, S., Lund-Johansen, F., Olweus, J. and Kolstad, A. (2022) Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination. Br J Haematol, 197, 697-708.
166. Risnes, L.F., Chlubnova, M., Magistrelli, E., Kemppainen, E., Hervonen, K., Mansikka, E., Lindfors, K., Salmi, T., Dahal-Koirala, S. and Sollid, L.M. (2023) Phenotypic Analysis of Disease-Relevant T Cells in Dermatitis Herpetiformis. J Invest Dermatol, 143, 163-166 e162.
167. Risnes, L.F., Eggesbo, L.M., Zuhlke, S., Dahal-Koirala, S., Neumann, R.S., Lundin, K.E.A., Christophersen, A. and Sollid, L.M. (2021) Circulating CD103(+) gammadelta and CD8(+) T cells are clonally shared with tissue-resident intraepithelial lymphocytes in celiac disease. Mucosal Immunol, 14, 842-851.
168. Risnes, L.F., Reims, H.M., Doyle, R.M., Qiao, S.W., Sollid, L.M., Lundin, K.E.A. and Christophersen, A. (2024) Gluten-Free Diet Induces Rapid Changes in Phenotype and Survival Properties of Gluten-Specific T Cells in Celiac Disease. Gastroenterology, 167, 250-263.
169. Rodland, G.E., Hauge, S., Hasvold, G., Bay, L.T.E., Raabe, T.T.H., Joel, M. and Syljuasen, R.G. (2021) Differential Effects of Combined ATR/WEE1 Inhibition in Cancer Cells. Cancers (Basel), 13.
170. Romaine, A., Melleby, A.O., Alam, J., Lobert, V.H., Lu, N., Lockwood, F.E., Hasic, A., Lunde, I.G., Sjaastad, I., Stenmark, H., Herum, K.M., Gullberg, D. and Christensen, G. (2022) Integrin alpha11beta1 and syndecan-4 dual receptor ablation attenuate cardiac hypertrophy in the pressure overloaded heart. Am J Physiol Heart Circ Physiol, 322, H1057-H1071.
171. Rossevold, A.H., Andresen, N.K., Bjerre, C.A., Gilje, B., Jakobsen, E.H., Raj, S.X., Falk, R.S., Russnes, H.G., Jahr, T., Mathiesen, R.R., Lomo, J., Garred, O., Chauhan, S.K., Lereim, R.R., Dunn, C., Naume, B. and Kyte, J.A. (2022) Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial. Nat Med, 28, 2573-2583.
172. Rye, I.H., Huse, K., Josefsson, S.E., Kildal, W., Danielsen, H.E., Schlichting, E., Garred, O., Riis, M.L., Osbreac, Lingjaerde, O.C., Myklebust, J.H. and Russnes, H.G. (2022) Breast cancer metastasis: immune profiling of lymph nodes reveals exhaustion of effector T cells and immunosuppression. Mol Oncol, 16, 88-103.
173. Rødland, G.E., Temelie, M., Serban, A.M., Eek Mariampillai, A., Edin, N.F.J., Malinen, E., Gilbert, A., Chevalier, F., Savu, D.I. and Syljuåsen, R.G. (2024) Interferon signaling is enhanced by ATR inhibition in glioblastoma cells irradiated with X-rays, protons or carbon ions. bioRxiv, 2024.2006.2012.598643.
174. Saidu, N.E.B., Aarsund, M., Sorensen, E., Stensland, M., Nyman, T.A., Ulvmoen, A., Wu, Y. and Inngjerdingen, M. (2024) Identifying a core protein signature of small extracellular vesicles derived from B-cell precursor acute lymphoblastic leukaemia. Scand J Immunol, 99, e13341.
175. Schink, K.O., Tan, K.W., Spangenberg, H., Martorana, D., Sneeggen, M., Stevenin, V., Enninga, J., Campsteijn, C., Raiborg, C. and Stenmark, H. (2021) The phosphoinositide coincidence detector Phafin2 promotes macropinocytosis by coordinating actin organisation at forming macropinosomes. Nat Commun, 12, 6577.
176. Schultz, N.H., Soraas, A.V.L., Sorvoll, I.H., Akkok, C.A., Vetlesen, A., Bhamra, J.S., Ahlen, M.T., Holme, P.A., Aamodt, A.H., Skagen, K., Skattor, T.H., Skjelland, M. and Wiedmann, M.K. (2023) Vaccine associated benign headache and cutaneous hemorrhage after ChAdOx1 nCoV-19 vaccine: A cohort study. J Stroke Cerebrovasc Dis, 32, 106860.
177. Schultz, N.H., Sorvoll, I.H., Michelsen, A.E., Munthe, L.A., Lund-Johansen, F., Ahlen, M.T., Wiedmann, M., Aamodt, A.H., Skattor, T.H., Tjonnfjord, G.E. and Holme, P.A. (2021) Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. N Engl J Med, 384, 2124-2130.
178. Selvakumar, J., Havdal, L.B., Drevvatne, M., Brodwall, E.M., Lund Berven, L., Stiansen-Sonerud, T., Einvik, G., Leegaard, T.M., Tjade, T., Michelsen, A.E., Mollnes, T.E., Lund-Johansen, F., Holmoy, T., Zetterberg, H., Blennow, K., Sandler, C.X., Cvejic, E., Lloyd, A.R. and Wyller, V.B.B. (2023) Prevalence and Characteristics Associated With Post-COVID-19 Condition Among Nonhospitalized Adolescents and Young Adults. JAMA Netw Open, 6, e235763.
179. Shekhar, S., Brar, N.K. and Petersen, F.C. (2023) Suppressive effect of therapeutic antibiotic regimen on antipneumococcal Th1/Th17 responses in neonatal mice. Pediatr Res, 93, 818-826.
180. Shemesh, O., Polak, P., Lundin, K.E.A., Sollid, L.M. and Yaari, G. (2021) Machine Learning Analysis of Naive B-Cell Receptor Repertoires Stratifies Celiac Disease Patients and Controls. Front Immunol, 12, 627813.
181. Sikkeland, L.I.B., Qiao, S.W., Ueland, T., Myrdal, O., Wyrozemski, L., Aukrust, P., Jahnsen, F.L., Sjaheim, T., Kongerud, J., Molberg, O., Lund, M.B. and Baekkevold, E.S. (2021) Lung CD4+ T-cells in patients with lung fibrosis produce pro-fibrotic interleukin-13 together with interferon-gamma. Eur Respir J, 57.
182. Skanland, S.S., Inngjerdingen, M., Bendiksen, H., York, J., Spetalen, S., Munthe, L.A. and Tjonnfjord, G.E. (2022) Functional testing of relapsed chronic lymphocytic leukemia guides precision medicine and maps response and resistance mechanisms. An index case. Haematologica, 107, 1994-1998.
183. Skogstad, M., Aass, H.C.D., Lunde, L.K., Skare, O., Sirnes, P.A. and Matre, D. (2022) A Cease in Shift Work Reverses Arterial Stiffness but Increases Weight and Glycosylated Hemoglobin A 5-Month Follow-Up in Industry. J Cardiovasc Dev Dis, 9.
184. Skogstad, M., Aass, H.C.D., Sirnes, P.A., Mamen, A., Skare, O., Matre, D., Hammer, S.E., Goffeng, E. and Lunde, L.K. (2023) Influence of Shift Work on Arterial Stiffness and Systemic Inflammation: A 3-Year Follow-up Study in Industry. J Occup Environ Med, 65, 284-291.
185. Soegaard, E.G.I., Kan, Z., Aass, H.C.D., Koirala, R., Hauff, E. and Thapa, S.B. (2022) Abnormal Cytokines in Trauma Patients Explained by Obesity, Musculoskeletal Disease, Smoking, and Lung Disease. Neuropsychobiology, 81, 516-530.
186. Sohlberg, E., Pfefferle, A., Heggernes Ask, E., Tschan-Plessl, A., Jacobs, B., Netskar, H., Lorenz, S., Kanaya, M., Kosugi-Kanaya, M., Meinke, S., Mortberg, A., Hoglund, P., Sundin, M., Carlsson, G., Palmblad, J. and Malmberg, K.J. (2022) Perturbed NK-cell homeostasis associated with disease severity in chronic neutropenia. Blood, 139, 704-716.
187. Solhaug, M.B., Schreurs, O., Schenck, K., Blix, I.J. and Baekkevold, E.S. (2022) Origin of langerin (CD207)-expressing antigen presenting cells in the normal oral mucosa and in oral lichen planus lesions. Eur J Oral Sci, 130, e12835.
188. Soraas, A., Grodeland, G., Granerud, B.K., Ueland, T., Lind, A., Fevang, B., Murphy, S.L., Huse, C., Nygaard, A.B., Steffensen, A.K., Al-Baldawi, H., Holberg-Petersen, M., Andresen, L.L., Agnes, C., Ranheim, T., Schanke, Y., Istre, M., Dahl, J.A., Chopra, A., Dudman, S., Kaarbo, M., Andersen, J.T., Vaage, E.B., Tran, T.T., Vaage, J.T., Michelsen, A.E., Muller, F., Aukrust, P., Halvorsen, B., Dahl, T.B., Holter, J.C. and Lund-Johansen, F. (2022) Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity. Front Immunol, 13, 964525.
189. Spasevska, I., Sharma, A., Steen, C.B., Josefsson, S.E., Blaker, Y.N., Kolstad, A., Rustad, E.H., Meyer, S., Isaksen, K., Chellappa, S., Kushekhar, K., Beiske, K., Forsund, M.S., Spetalen, S., Holte, H., Ostenstad, B., Brodtkorb, M., Kimby, E., Olweus, J., Tasken, K., Newman, A.M., Lorenz, S., Smeland, E.B., Alizadeh, A.A., Huse, K. and Myklebust, J.H. (2023) Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma. Blood Adv, 7, 7216-7230.
190. Spildrejorde, M., Leithaug, M., Samara, A., Aass, H.C.D., Sharma, A., Acharya, G., Nordeng, H., Gervin, K. and Lyle, R. (2024) Citalopram exposure of hESCs during neuronal differentiation identifies dysregulated genes involved in neurodevelopment and depression. Front Cell Dev Biol, 12, 1428538.
191. Stonyte, V., Mastrangelopoulou, M., Timmer, R., Lindbergsengen, L., Vietri, M., Campsteijn, C. and Grallert, B. (2023) The GCN2/eIF2alphaK stress kinase regulates PP1 to ensure mitotic fidelity. EMBO Rep, 24, e56100.
192. Sudworth, A., Segers, F.M., Yilmaz, B., Guslund, N.C., Macpherson, A.J., Dissen, E., Qiao, S.W. and Inngjerdingen, M. (2022) Innate lymphoid cell characterization in the rat and their correlation to gut commensal microbes. Eur J Immunol, 52, 717-729.
193. Syversen, S.W., Jyssum, I., Tveter, A.T., Tran, T.T., Sexton, J., Provan, S.A., Mjaaland, S., Warren, D.J., Kvien, T.K., Grodeland, G., Nissen-Meyer, L.S.H., Ricanek, P., Chopra, A., Andersson, A.M., Kro, G.B., Jahnsen, J., Munthe, L.A., Haavardsholm, E.A., Vaage, J.T., Lund-Johansen, F., Jorgensen, K.K. and Goll, G.L. (2022) Immunogenicity and Safety of Standard and Third-Dose SARS-CoV-2 Vaccination in Patients Receiving Immunosuppressive Therapy. Arthritis Rheumatol, 74, 1321-1332.
194. Szabo, K., Jambor, I., Szanto, A., Horvath, I.F., Tarr, T., Nakken, B., Szodoray, P. and Papp, G. (2021) The Imbalance of Circulating Follicular T Helper Cell Subsets in Primary Sjogren's Syndrome Associates With Serological Alterations and Abnormal B-Cell Distribution. Front Immunol, 12, 639975.
195. Szodoray, P., Andersen, T.K., Heinzelbecker, J., Imbery, J.F., Huszthy, P.C., Stanford, S.M., Bogen, B., Landsverk, O.B., Bottini, N., Tveita, A., Munthe, L.A. and Nakken, B. (2021) Integration of T helper and BCR signals governs enhanced plasma cell differentiation of memory B cells by regulation of CD45 phosphatase activity. Cell Rep, 36, 109525.
196. Tadele, D.S., Robertson, J., Crispin, R., Herrera, M.C., Chlubnova, M., Piechaczyk, L., Ayuda-Duran, P., Singh, S.K., Gedde-Dahl, T., Floisand, Y., Skavland, J., Wesche, J., Gjertsen, B.T. and Enserink, J.M. (2021) A cell competition-based small molecule screen identifies a novel compound that induces dual c-Myc depletion and p53 activation. J Biol Chem, 296, 100179.
197. Tan, K.W., Nahse, V., Campsteijn, C., Brech, A., Schink, K.O. and Stenmark, H. (2021) JIP4 is recruited by the phosphoinositide-binding protein Phafin2 to promote recycling tubules on macropinosomes. J Cell Sci, 134.
198. Tellez-Gabriel, M., Tekpli, X., Reine, T.M., Hegge, B., Nielsen, S.R., Chen, M., Moi, L., Normann, L.S., Busund, L.R., Calin, G.A., Maelandsmo, G.M., Perander, M., Theocharis, A.D., Kolset, S.O. and Knutsen, E. (2022) Serglycin Is Involved in TGF-beta Induced Epithelial-Mesenchymal Transition and Is Highly Expressed by Immune Cells in Breast Cancer Tissue. Front Oncol, 12, 868868.
199. Tesfaye, D.Y., Bobic, S., Lysen, A., Huszthy, P.C., Gudjonsson, A., Braathen, R., Bogen, B. and Fossum, E. (2022) Targeting Xcr1 on Dendritic Cells Rapidly Induce Th1-Associated Immune Responses That Contribute to Protection Against Influenza Infection. Front Immunol, 13, 752714.
200. Tjarnhage, E., Brown, D., Bogen, B., Andersen, T.K. and Grodeland, G. (2023) Trimeric, APC-Targeted Subunit Vaccines Protect Mice against Seasonal and Pandemic Influenza. J Virol, 97, e0169422.
201. Tran, T.T., Vaage, E.B., Mehta, A., Chopra, A., Tietze, L., Kolderup, A., Anthi, A., Konig, M., Nygaard, G., Lind, A., Muller, F., Nissen-Meyer, L.S., Magnus, P., Trogstad, L., Mjaaland, S., Soraas, A., Midtvedt, K., Asberg, A., Barratt-Due, A., Medhus, A.W., Hoivik, M.L., Lundin, K., Karlsen, R.F., Dahle, R., Danielsson, K., Thomassen, K.S., Kro, G.B., Cox, R.J., Zhou, F., Langeland, N., Aukrust, P., Melum, E., Avitsland, T.L., Wiencke, K., Holter, J.C., Munthe, L.A., Grodeland, G., Andersen, J.T., Vaage, J.T. and Lund-Johansen, F. (2022) Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants. NPJ Vaccines, 7, 174.
202. Troseid, M., Arribas, J.R., Assoumou, L., Holten, A.R., Poissy, J., Terzic, V., Mazzaferri, F., Bano, J.R., Eustace, J., Hites, M., Joannidis, M., Paiva, J.A., Reuter, J., Puntmann, I., Patrick-Brown, T., Westerheim, E., Nezvalova-Henriksen, K., Beniguel, L., Dahl, T.B., Bouscambert, M., Halanova, M., Peterfi, Z., Tsiodras, S., Rezek, M., Briel, M., Unal, S., Schlegel, M., Ader, F., Lacombe, K., Amdal, C.D., Rodrigues, S., Tonby, K., Gaudet, A., Heggelund, L., Mootien, J., Johannessen, A., Moller, J.H., Pollan, B.D., Tveita, A.A., Kildal, A.B., Richard, J.C., Dalgard, O., Simensen, V.C., Balde, A., de Gastines, L., Del Alamo, M., Aydin, B., Lund-Johansen, F., Trabaud, M.A., Diallo, A., Halvorsen, B., Rottingen, J.A., Tacconelli, E., Yazdanpanah, Y., Olsen, I.C., Costagliola, D. and group, E.U.S.s. (2023) Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial. Crit Care, 27, 9.
203. Tschan-Plessl, A., Kalberer, C.P., Wieboldt, R., Stern, M., Siegler, U., Wodnar-Filipowicz, A., Gerull, S., Halter, J., Heim, D., Tichelli, A., Tsakiris, D.A., Malmberg, K.J., Passweg, J.R. and Bottos, A. (2021) Cellular immunotherapy with multiple infusions of in vitro-expanded haploidentical natural killer cells after autologous transplantation for patients with plasma cell myeloma. Cytotherapy, 23, 329-338.
204. Tunheim, G., Ro, G.O.I., Chopra, A., Aase, A., Kran, A.B., Vaage, J.T., Lund-Johansen, F. and Hungnes, O. (2022) Prevalence of antibodies against SARS-CoV-2 in the Norwegian population, August 2021. Influenza Other Respir Viruses, 16, 1004-1013.
205. Tunheim, G., Ro, G.O.I., Tran, T., Kran, A.B., Andersen, J.T., Vaage, E.B., Kolderup, A., Vaage, J.T., Lund-Johansen, F. and Hungnes, O. (2022) Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemic. Influenza Other Respir Viruses, 16, 204-212.
206. Ulvmoen, A., Greiff, V., Bechensteen, A.G. and Inngjerdingen, M. (2024) NKG2A discriminates natural killer cells with a suppressed phenotype in pediatric acute leukemia. J Leukoc Biol, 115, 334-343.
207. Valsalakumari, R., Pandya, A.D., Prasmickaite, L., Kvalvaag, A., Myrann, A.G., Aslund, A.K.O., Kjos, M.S., Fontecha-Cuenca, C., Haroon, H.B., Ribeiro, A.R.S., Horejs-Hoeck, J., Moghimi, S.M., Morch, Y., Skotland, T., Sandvig, K., Maelandsmo, G.M. and Iversen, T.G. (2024) Preclinical Efficacy of Cabazitaxel Loaded Poly(2-alkyl cyanoacrylate) Nanoparticle Variants. Int J Nanomedicine, 19, 3009-3029.
208. Valsalakumari, R., Yadava, S.K., Szwed, M., Pandya, A.D., Maelandsmo, G.M., Torgersen, M.L., Iversen, T.G., Skotland, T., Sandvig, K. and Giri, J. (2021) Mechanism of cellular uptake and cytotoxicity of paclitaxel loaded lipid nanocapsules in breast cancer cells. Int J Pharm, 597, 120217.
209. Vestad, B., Nyman, T.A., Hove-Skovsgaard, M., Stensland, M., Hoel, H., Troseid, A.S., Aspelin, T., Aass, H.C.D., Puhka, M., Hov, J.R., Nielsen, S.D., Ovstebo, R. and Troseid, M. (2021) Plasma extracellular vesicles in people living with HIV and type 2 diabetes are related to microbial translocation and cardiovascular risk. Sci Rep, 11, 21936.
210. Vikan, A.K., Kostas, M., Haugsten, E.M., Selbo, P.K. and Wesche, J. (2021) Efficacy and Selectivity of FGF2-Saporin Cytosolically Delivered by PCI in Cells Overexpressing FGFR1. Cells, 10.
211. Villatoro, A., Cuminetti, V., Bernal, A., Torroja, C., Cossio, I., Benguria, A., Ferre, M., Konieczny, J., Vazquez, E., Rubio, A., Utnes, P., Tello, A., You, X., Fenton, C.G., Paulssen, R.H., Zhang, J., Sanchez-Cabo, F., Dopazo, A., Vik, A., Anderssen, E., Hidalgo, A. and Arranz, L. (2023) Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation. Nat Commun, 14, 12.
212. Wang, C., Abadpour, S., Aizenshtadt, A., Dalmao-Fernandez, A., Hoyem, M., Wilhelmsen, I., Stokowiec, J., Olsen, P.A., Krauss, S., Chera, S., Ghila, L., Raeder, H. and Scholz, H. (2024) Cell identity dynamics and insight into insulin secretagogues when employing stem cell-derived islets for disease modeling. Front Bioeng Biotechnol, 12, 1392575.
213. Wang, C., Abadpour, S., Olsen, P.A., Wang, D., Stokowiec, J., Chera, S., Ghila, L., Raeder, H., Krauss, S., Aizenshtadt, A. and Scholz, H. (2024) Glucose Concentration in Regulating Induced Pluripotent Stem Cells Differentiation Toward Insulin-Producing Cells. Transpl Int, 37, 11900.
214. Werninghaus, I.C., Hinke, D.M., Fossum, E., Bogen, B. and Braathen, R. (2023) Neuraminidase delivered as an APC-targeted DNA vaccine induces protective antibodies against influenza. Mol Ther, 31, 2188-2205.
215. Westhrin, M., Blazevski, J., Textor, A., Abdollahi, P., Gopalakrishnan, R.P., Ngo, L.T., Hofgaard, P.O., Heinzelbecker, J., Bobic, S., Fossum, E., Spang, H.C.L., Braathen, R. and Bogen, B. (2023) Id-neoantigen vaccine induces therapeutic CD8(+) T cells against multiple myeloma: H chain-loss escapees cause FLC MM. J Immunother Cancer, 11.
216. Wilhelmsen, I., Amirola Martinez, M., Stokowiec, J., Wang, C., Aizenshtadt, A. and Krauss, S. (2023) Characterization of human stem cell-derived hepatic stellate cells and liver sinusoidal endothelial cells during extended in vitro culture. Front Bioeng Biotechnol, 11, 1223737.
217. Wilhelmsen, I., Combriat, T., Dalmao-Fernandez, A., Stokowiec, J., Wang, C., Olsen, P.A., Wik, J.A., Boichuk, Y., Aizenshtadt, A. and Krauss, S. (2024) The effects of TGF-beta-induced activation and starvation of vitamin A and palmitic acid on human stem cell-derived hepatic stellate cells. Stem Cell Res Ther, 15, 223.
218. Wold, C.W., Christopoulos, P.F., Arias, M.A., Dzovor, D.E., Oynebraten, I., Corthay, A. and Inngjerdingen, K.T. (2024) Fungal polysaccharides from Inonotus obliquus are agonists for Toll-like receptors and induce macrophage anti-cancer activity. Commun Biol, 7, 222.
219. Wolf, A.S., Ravussin, A., Konig, M., Overas, M.H., Solum, G., Kjonstad, I.F., Chopra, A., Holmoy, T., Harbo, H.F., Syversen, S.W., Jorgensen, K.K., Hogestol, E.A., Vaage, J.T., Celius, E.G., Lund-Johansen, F., Munthe, L.A., Nygaard, G.O. and Mjaaland, S. (2023) T cell responses to SARS-CoV-2 vaccination differ by disease-modifying therapy for multiple sclerosis. JCI Insight, 8.
220. Wong, J.J.W. and Selbo, P.K. (2021) Light-controlled elimination of PD-L1+ cells. J Photochem Photobiol B, 225, 112355.
221. Wyrozemski, L., Sollid, L.M. and Qiao, S.W. (2021) C-type lectin-like CD161 is not a co-signalling receptor in gluten-reactive CD4 + T cells. Scand J Immunol, 93, e13016.
222. Wüsthoff, L.E.C., Lund-Johansen, F., Henriksen, K., Wildendahl, G., Jacobsen, J.A., Gomes, L., Anjum, H.S., Barlinn, R., Kran, A.B., Munthe, L.A. and Vaage, J.T. (2024) Seroprevalence of SARS-CoV-2 and humoral immune responses to COVID-19 mRNA vaccines among people who use drugs - in the light of tailored mitigating strategies. Harm Reduct J, 21, 120.
223. Yao, Y., Wyrozzemski, L., Lundin, K.E.A., Sandve, G.K. and Qiao, S.W. (2021) Differential expression profile of gluten-specific T cells identified by single-cell RNA-seq. PLoS One, 16, e0258029.
224. Yin, Y., Athanasiadis, P., Karlsen, L., Urban, A., Xu, H., Murali, I., Fernandes, S.M., Arribas, A.J., Hilli, A.K., Tasken, K., Bertoni, F., Mato, A.R., Normant, E., Brown, J.R., Tjonnfjord, G.E., Aittokallio, T. and Skanland, S.S. (2022) Functional Testing to Characterize and Stratify PI3K Inhibitor Responses in Chronic Lymphocytic Leukemia. Clin Cancer Res, 28, 4444-4455.
225. Zhou, C., Osterbye, T., Bach, E., Dahal-Koirala, S., Hoydahl, L.S., Steinsbo, O., Jahnsen, J., Lundin, K.E.A., Buus, S., Sollid, L.M. and Iversen, R. (2022) Focused B cell response to recurring gluten motif with implications for epitope spreading in celiac disease. Cell Rep, 41, 111541.
226. Zlygosteva, O., Juvkam, I.S., Aass, H.C.D., Galtung, H.K., Soland, T.M., Malinen, E. and Edin, N.F.J. (2023) Cytokine Levels in Saliva Are Associated with Salivary Gland Fibrosis and Hyposalivation in Mice after Fractionated Radiotherapy of the Head and Neck. Int J Mol Sci, 24.